PubMedCrossRef 11. Dey BR, Sukhatme VP, Roberts
AB, Sporn MB, Rauscher FJ, Kim SJ: Repression of the transforming growth factor-beta 1 gene by the Wilms’ tumor suppressor WT1 gene product. Mol Endocrinol 1994, 8:595–602.PubMedCrossRef 12. Loeb DM: WT1 influences apoptosis through transcriptional regulation of Bcl-2 family members. Cell Cycle 2006, 5:1249–1253.PubMedCrossRef 13. Oh S, Song Y, Yim J, Kim TK: The Wilms’ tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene. J Biol Chem 1999, 274:37473–37478.PubMedCrossRef 14. Bergmann L, Miething C, Maurer U, Brieger J, Karakas T, Weidmann Selleckchem MCC-950 E, Hoelzer D: High levels of Wilms’ tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 1997, 90:1217–1225.PubMed 15. Morrison AA, Viney RL, Ladomery MR: The post-transcriptional roles of WT1, a multifunctional zinc-finger protein. Biochim Biophys Acta 2008, 1785:55–62.PubMed 16. Cilloni D, Gottardi E, De Micheli D, Serra A, Volpe G, Messa F, Rege-Cambrin G, Guerrasio A, Divona M, Lo Coco F, Saglio
G: Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients. Leukemia 2002, 16:2115–2121.PubMedCrossRef 17. Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Schoot E, Delabesse E, Macintyre E, Gottardi E, Saglio G, Watzinger F, Lion T, van Dongen JJ, HDAC inhibitor Hokland P, Gabert J: C188-9 mouse Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program. Leukemia 2003, 17:2474–2486.PubMedCrossRef 18. Gao SM, Chen C, Wu J, Tan Y, Yu K, Xing CY, Ye A, Yin L, Jiang L: Synergistic apoptosis induction in leukemic cells by miR-15a/16–1 and arsenic trioxide. Biochem Biophys Res Commun 2010, 403:203–208.PubMedCrossRef Urocanase 19. Glienke W, Maute L, Koehl U, Esser R, Milz E, Bergmann L: Effective treatment of
leukemic cell lines with wt1 siRNA. Leukemia 2007, 21:2164–2170.PubMedCrossRef 20. Lawrie CH: MicroRNAs and haematology: small molecules, big function. Br J Haematol 2007, 137:503–512.PubMedCrossRef 21. Eiring AM, Harb JG, Neviani P, Garton C, Oaks JJ, Spizzo R, Liu S, Schwind S, Santhanam R, Hickey CJ, Becker H, Chandler JC, Andino R, Cortes J, Hokland P, Huettner CS, Bhatia R, Roy DC, Liebhaber SA, Caligiuri MA, Marcucci G, Garzon R, Croce CM, Calin GA, Perrotti D: miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 140:652–665. 22. Calin GA, Croce CM: MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 2006, 66:7390–7394.PubMedCrossRef 23. Jing Q, Huang S, Guth S, Zarubin T, Motoyama A, Chen J, Di Padova F, Lin SC, Gram H, Han J: Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 2005, 120:623–634.